Structural Biology in Drug Design

Drug design is an innovative process to asset new medication based on the knowledge of biological target. Drug is most commonly a small molecule that inhibits or activates the function of a biomolecule, which in turn outcomes in a therapeutic benefit to the patient. Drug design commonly but not essentially relies on computational techniques. This type of modelling is often mentioned to as computer-aided drug design. Drug design that depends on the knowledge of the 3D structure of the target is known as structure-based drug design. The main methods available for drug design are structure based drug design and ligand based drug design.

  • Drug targets
  • Computer-aided drug design
  • Ligand-based design
  • Structure-based design
  • Binding site identification
  • Scoring functions

Related Conference of Structural Biology in Drug Design

June 13-14, 2024

30th Asia Pacific Biotechnology Congress

Dubai, UAE
July 11-12, 2024

6th International Conference on Biochemistry

Paris, France
September 25-26, 2024

20th World Congress on Structural Biology

Paris, France
October 03-04, 2024

15th International Conference on Biofuels and Bioenergy

Singapore City, Singapore
December 12-13, 2024

15th World Congress on Cell & Tissue Science

Rome, Italy

Structural Biology in Drug Design Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in